Hypopigmentation disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The metabolism of PI(3,5)P2 is regulated by the PIKfyve, VAC14 and FIG4 complex, mutations in which are associated with hypopigmentation in mice.
|
30709920 |
2019 |
Leukoencephalopathy
|
0.010 |
Biomarker
|
group |
BEFREE |
The families described here the expanded clinical spectrum of FIG4 deficiency to include leukoencephalopathy.
|
30740813 |
2019 |
ALBINOIDISM, OCULOCUTANEOUS, AUTOSOMAL DOMINANT
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The metabolism of PI(3,5)P2 is regulated by the PIKfyve, VAC14 and FIG4 complex, mutations in which are associated with hypopigmentation in mice.
|
30709920 |
2019 |
Spastic Paraplegia Type 7
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Previous studies have demonstrated that mutations in ALSIN, spastic paraplegia 7 (SPG7), TBK1, ALS2, ERLIN2, and FIG4 are responsible for PLS.
|
31117107 |
2019 |
Action Tremor
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Constitutive Fig4-/- mice exhibit intention tremor, spongiform degeneration of neural tissue, hypomyelination, and juvenile lethality.
|
29688489 |
2018 |
Intention tremor
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Constitutive Fig4-/- mice exhibit intention tremor, spongiform degeneration of neural tissue, hypomyelination, and juvenile lethality.
|
29688489 |
2018 |
Hypertensive disease
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Six risk factors were independently associated with PNC and comprised the PNC score (PNC score, 0-16 points): hypertension (2 points), Hunt-Hess grade ≥4 (3 points), Fisher grade ≥3 (2 points), wide-necked aneurysm (2 points), with a bleb on the aneurysm sac (3 points), and aneurysm size (3-10 mm, 1 point; <3 mm, 4 points).
|
28153618 |
2017 |
Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In support of this role of ES to regulate neural crest-derived cell fate and differentiation in vivo, knockdown of FIG4 in neuroblastoma cells resulted in vacuologenesis and cell degeneration, whereas ES treatment after FIG4-small interfering RNA transfection enhanced neural differentiation, survival, and integrity.
|
27856290 |
2017 |
Central neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In support of this role of ES to regulate neural crest-derived cell fate and differentiation in vivo, knockdown of FIG4 in neuroblastoma cells resulted in vacuologenesis and cell degeneration, whereas ES treatment after FIG4-small interfering RNA transfection enhanced neural differentiation, survival, and integrity.
|
27856290 |
2017 |
Childhood Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In support of this role of ES to regulate neural crest-derived cell fate and differentiation in vivo, knockdown of FIG4 in neuroblastoma cells resulted in vacuologenesis and cell degeneration, whereas ES treatment after FIG4-small interfering RNA transfection enhanced neural differentiation, survival, and integrity.
|
27856290 |
2017 |
Epilepsy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in Factor-Induced-Gene 4 (FIG4) gene have been identified in Charcot-Marie-Tooth disease type 4J (CMT4J), Yunis-Varon syndrome and epilepsy with polymicrogyria.
|
26708557 |
2016 |
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations of FIG4 result in the inherited disorders Charcot-Marie-Tooth disease type 4J, Yunis-Varón syndrome, and polymicrogyria with seizures.
|
27292112 |
2016 |
Congenital Abnormality
|
0.010 |
GeneticVariation
|
group |
BEFREE |
This study extends the spectrum of phenotypes associated with FIG4 mutations to include cortical malformation associated with seizures and psychiatric manifestations, in addition to the previously described Charcot-Marie-Tooth disease type 4J and Yunis-Varón syndrome.
|
24598713 |
2014 |
Deformity
|
0.010 |
GeneticVariation
|
group |
BEFREE |
This study extends the spectrum of phenotypes associated with FIG4 mutations to include cortical malformation associated with seizures and psychiatric manifestations, in addition to the previously described Charcot-Marie-Tooth disease type 4J and Yunis-Varón syndrome.
|
24598713 |
2014 |
Familial Epilepsies
|
0.010 |
Biomarker
|
disease |
BEFREE |
Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria.
|
24598713 |
2014 |
Malignant neoplasm of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
Database analyses, discussed herein, reinforce the involvement of Sac3 in breast cancer pathogenesis.
|
24070605 |
2013 |
Demyelinating Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
We also discuss the implications of FIG4/PI(3,5)P(2) signaling in understanding other lysosomal storage diseases, neuropathies, and acquired demyelinating diseases.
|
23165282 |
2013 |
Lysosomal Storage Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
We also discuss the implications of FIG4/PI(3,5)P(2) signaling in understanding other lysosomal storage diseases, neuropathies, and acquired demyelinating diseases.
|
23165282 |
2013 |
Neurodegenerative Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Interestingly, FIG4 mutations were previously reported to be responsible for other neurodegenerative diseases such as autosomal recessive Charcot-Marie-Tooth disease type 4J and autosomal dominant amyotrophic lateral sclerosis/primary lateral sclerosis.
|
24088667 |
2013 |
Inherited neuropathies
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
CMT4J secondary to FIG4 mutations should be added to the list of inherited neuropathies that need to be considered in suspected cases of inflammatory demyelinating neuropathy, especially if there is a background history of a more slowly progressive neuropathy.
|
23489662 |
2013 |
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Database analyses, discussed herein, reinforce the involvement of Sac3 in breast cancer pathogenesis.
|
24070605 |
2013 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, FIG4 mutations were previously reported to be responsible for other neurodegenerative diseases such as autosomal recessive Charcot-Marie-Tooth disease type 4J and autosomal dominant amyotrophic lateral sclerosis/primary lateral sclerosis.
|
24088667 |
2013 |
Triple Negative Breast Neoplasms
|
0.010 |
Biomarker
|
disease |
BEFREE |
Together, our results uncover an unexpected role for Sac3 phosphatase in TNBC cell proliferation.
|
24070605 |
2013 |
Abnormality of the skeletal system
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
This genotype-phenotype correlation demonstrates that absence of FIG4 activity leads to central nervous system dysfunction and extensive skeletal anomalies.
|
23623387 |
2013 |
Motor neuron atrophy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Humans with a deficiency of FIG4 (known as Charcot-Marie-Tooth disease type 4J or CMT4J) present with clinical and pathophysiological phenotypes indicative of spinal motor neuron degeneration and segmental demyelination.
|
23165282 |
2013 |